Retrospective Medical Chart Review Study to Describe the Experience of SLE Patients Treated With Anifrolumab in the Early Access Programs

Condition:   Systemic Lupus Erythematosus Intervention:   Other: None (Observational study) Sponsors:   AstraZeneca;   CernerEnviza Not yet recruiting

Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials